Literature DB >> 9116755

Growth factors and renal cancer: characterization and therapeutic implications.

J H Mydlo1.   

Abstract

The heterogeneiety renal-cell carcinoma can lead to unpredictable behavior: the ability to achieve a large volume yet not metastasize, the ability to demonstrate late recurrence or spontaneous regression, or the capability to metastasize at a relatively small volume. One-third of all patients who undergo radical nephrectomy for presumed localized disease will eventually have metastasis. Since renal-cell carcinoma is not significantly radio- or chemosensitive, it is important to investigate new avenues for treatment of this tumor once it has spread, specifically at the molecular level. This review discusses the most recent work on growth factors and renal cancer and proposes possible modalities for treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9116755     DOI: 10.1007/bf00191217

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  55 in total

Review 1.  Suramin as an archetypical compound in the development of growth factor antagonists for inhibition of genitourinary tumors.

Authors:  H I Scher; W D Heston
Journal:  Cancer Treat Res       Date:  1992

2.  End stage renal disease serum contains a specific renal cell growth factor.

Authors:  L H Klotz; C Kulkarni; G Mills
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

3.  A sensitive enzyme immunoassay for human basic fibroblast growth factor.

Authors:  H Watanabe; A Hori; M Seno; Y Kozai; K Igarashi; Y Ichimori; K Kondo
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

4.  Interleukin-6 and renal cell cancer: production, regulation, and growth effects.

Authors:  A S Koo; C Armstrong; B Bochner; T Shimabukuro; C L Tso; J B deKernion; A Belldegrum
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  The epidermal growth factor receptor and the prognosis of bladder cancer.

Authors:  D E Neal; L Sharples; K Smith; J Fennelly; R R Hall; A L Harris
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

6.  Analysis of growth factors in renal cell carcinoma.

Authors:  T Nakamoto; A Usui; K Oshima; H Ikemoto; S Mitani; T Usui
Journal:  Biochem Biophys Res Commun       Date:  1988-06-16       Impact factor: 3.575

7.  A pilot study of suramin in the treatment of metastatic renal cell carcinoma.

Authors:  R V La Rocca; C A Stein; R Danesi; M R Cooper; M Uhrich; C E Myers
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

8.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.

Authors:  M Nguyen; H Watanabe; A E Budson; J P Richie; D F Hayes; J Folkman
Journal:  J Natl Cancer Inst       Date:  1994-03-02       Impact factor: 13.506

9.  Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue.

Authors:  J H Mydlo; J Michaeli; C Cordon-Cardo; A S Goldenberg; W D Heston; W R Fair
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

10.  The effects of basic fibroblast growth factor and suramin on cell motility and growth of rat prostate cancer cells.

Authors:  K J Pienta; W B Isaacs; D Vindivich; D S Coffey
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

View more
  3 in total

1.  Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis.

Authors:  Jeong Seok Hwa; Hyo Jin Park; Jae Hun Jung; Sung Chul Kam; Hyung Chul Park; Choong Won Kim; Kee Ryeon Kang; Jea Seog Hyun; Ky Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

2.  Establishment and characterization of a highly immunogenic human renal carcinoma cell line.

Authors:  Clelia Prattichizzo; Margherita Gigante; Paola Pontrelli; Alessandro Stella; Maria Teresa Rocchetti; Maddalena Gigante; Eugenio Maiorano; Wolfgang Herr; Michele Battaglia; Loreto Gesualdo; Elena Ranieri
Journal:  Int J Oncol       Date:  2016-05-27       Impact factor: 5.650

3.  Two single nucleotide polymorphisms in the von Hippel-Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma.

Authors:  Wen-Chung Wang; Mei-Hua Tsou; Hui-Ju Chen; Wei-Fang Hsu; Yen-Chein Lai
Journal:  BMC Res Notes       Date:  2014-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.